Hyderabad-based Sai Parenterals Limited has successfully raised Rs 50 crore in equity funding. This round was led by marquee investors such as Samarsh Capital, Vyom Partners, and funds associated with Blue Lotus Capital.
The company said this investment will fuel its next phase of growth as it focuses on expanding into regulated international markets, acquiring new assets, and boosting its manufacturing footprint. Sai Parenterals aims to become a leading name in the global pharmaceutical industry.
Strategic Goals Ahead
Managing Director Anil Karusala shared that the company is focused on building a world-class pharmaceutical enterprise that meets the highest international quality and compliance standards. With this funding, Sai Parenterals will look to expand its product range, international footprint, and capabilities in sterile injectable production.
The company also plans to invest in intellectual property acquisition, improve manufacturing facilities, and enter new territories to offer affordable, high-quality healthcare products globally.
Investor Confidence Grows
Speaking on behalf of investors, Harikrishnan S, Managing Partner at Blue Lotus Capital, noted their continued trust in Sai Parenterals. He emphasized the company’s science-driven culture, scalable platform, and strategic position in sterile injectables.
He added that this partnership is expected to enhance access to quality healthcare solutions in both developed and emerging markets while creating sustained value for stakeholders.
Business Model Supports Growth
Sai Parenterals operates under two core business verticals: Branded Export Formulations and Contract Development & Manufacturing Organization (CDMO) Services. Through these models, the company delivers value-added drug formulations to partners across India and abroad.
Its product portfolio includes injectables, oral solids and liquids, and topical drugs. The company is actively involved in research, development, regulatory affairs, and marketing, covering the full pharmaceutical lifecycle.
What is Sai Parenterals
Sai Parenterals Limited is an Indian pharmaceutical company based in Hyderabad. It specializes in formulation development, sterile injectables, and global pharmaceutical exports.
The company runs five manufacturing facilities across India, some of which are approved by global regulatory authorities like TGA Australia, SAPRA, GCC, and WHO GMP. These certifications help the company maintain its growing presence in regulated markets and support international expansion.
With a vision rooted in scientific innovation and global quality, Sai Parenterals continues to build a reputation as a reliable partner in healthcare manufacturing and exports.
